Compare
UFP Technologies Inc vs Alphatec Holdings, Inc. vs Orthofix Medical Inc. vs Artivion, Inc.
| Latest fiscal year | UFP Technologies Inc UFPT | Alphatec Holdings, Inc. ATEC | Orthofix Medical Inc. OFIX | Artivion, Inc. AORT |
|---|---|---|---|---|
| Year ended | 2025-12-31 | 2025-12-31 | 2025-12-31 | 2025-12-31 |
| Revenue | $602.80M | $764.15M | $822.31M | $441.33M |
| Revenue growth (YoY) | +19.5% | +25.0% | +2.9% | +13.6% |
| Gross margin | 28.3% | 69.6% | 68.8% | 64.4% |
| Operating margin | 15.3% | -10.7% | -9.9% | 7.6% |
| Net margin | 11.3% | -18.8% | -11.2% | 2.2% |
| Net income | $68.31M | -$143.36M | -$92.19M | $9.77M |
| EPS (Diluted) | $8.75 | -$0.96 | -$2.33 | $0.21 |
| Operating cash flow | $91.91M | $45.23M | $33.35M | $39.88M |
| Free cash flow | n/a | $2.78M | -$1.28M | $839.0K |
| Cash & equivalents | $20.30M | $160.81M | $82.03M | $64.91M |
| Total assets | $655.08M | $791.21M | $850.65M | $884.80M |
| Total liabilities | $231.20M | n/a | $400.61M | $436.56M |
| Shareholders' equity | $423.88M | $12.43M | $450.04M | $448.23M |
| Return on year-end equity | 16.1% | n/m | -20.5% | 2.2% |
| Shares outstanding | 7.71M | 150.26M | 39.83M | n/a |
Revenue, most recent five fiscal years
| Fiscal year | UFP Technologies Inc | Alphatec Holdings, Inc. | Orthofix Medical Inc. | Artivion, Inc. |
|---|---|---|---|---|
| Latest | $602.80M Ended 2025-12-31 | $764.15M Ended 2025-12-31 | $822.31M Ended 2025-12-31 | $441.33M Ended 2025-12-31 |
| 1 year earlier | $504.42M Ended 2024-12-31 | $611.56M Ended 2024-12-31 | $799.49M Ended 2024-12-31 | $388.54M Ended 2024-12-31 |
| 2 years earlier | $400.07M Ended 2023-12-31 | $482.26M Ended 2023-12-31 | $746.64M Ended 2023-12-31 | $354.00M Ended 2023-12-31 |
| 3 years earlier | $353.79M Ended 2022-12-31 | $350.87M Ended 2022-12-31 | $460.71M Ended 2022-12-31 | $313.79M Ended 2022-12-31 |
| 4 years earlier | $206.32M Ended 2021-12-31 | $243.21M Ended 2021-12-31 | $464.48M Ended 2021-12-31 | $298.84M Ended 2021-12-31 |